Riboksin, ntụziaka na-egosi, onunu ogwu, mmetụta na contraindications pobochnymu

"Riboxinum" na-emepụta n'ụdị mbadamba ma ọ bụ na ihe ngwọta maka igba ogwu n'akwara ochichi. N'ọrụ umi nkwadebe bụ inosine, bụ ìgwè nke ndị na-emepụta ọgwụ mmadụ na normalize ndị myocardial metabolism, belata anụ ahụ hypoxia.

"Riboxinum" ntụziaka egosi eliminates arrhythmia enhances metabolic Filiks ke myocardium, mma nrugharị oxygen ke idem. Inosine achịkwakwa ume itule agha, na-eweghachi akwara mgbasa, na-egbochi nsogbu mgbe intraoperative gbasara akụrụ ischemia. "Riboksin" abuana ke assimilation nke glucose ike imetụta metabolism n'oge hypoxia, ọbụna ọnọdụ nke erughi nke adenosine triphosphate.

"Riboxinum", ntụziaka ezipụta edinam activates pyruvic acid, si otú na-enye a anụ ahụ respiration; na-akpali akpali utịp ke njikọ nke nucleotides. The ọgwụ na-enwekwu ọrụ nke ụfọdụ enzymes gụnyere ndị Krebs okirikiri. Inosine penetrates n'ime mkpụrụ ndụ, enwekwu ike nke contractions nke obi muscle, na myocardium-eme ka mgbe diastolic ọrụ, dị ka a N'ihi enwekwu ọbara olu ozi.

The ọgwụ na-ebelata ihe guzobere platelet enwekwu regenerative ike nke anụ ahụ, dị ka mucous membranes nke afo na eriri afọ ya, myocardium.

"Riboksin" na-egosi maka ojiji

The ọgwụ na-zubere maka integrated ọgwụgwọ nke okenye na ịrịa ọrịa obi, ghara ịgbanwe mgbe myocardial infarction na gbasara obi arrhythmia, nke na-akpata iji ihe gbasara obi glycosides.

Inosine ndinọ na ọtụtụ imeju ọrịa: ịba ọcha n'anya, imeju, imeju abụba mbelata (dị ka a n'ihi nke ịṅụbiga mmanya ókè, ịṅụ ọgwụ ọjọọ); mgbe urokoproporfirii.

"Riboksin" ntụziaka dosing

The ọgwụ na mbadamba na-atụ aro n'ihi na ndị okenye na-enweta tupu nri.

The kwa ụbọchị dose họrọ si 0,6 g na 2.4 g kwa ụbọchị dose nke nta nke nta ụba si 0,6 g na portability nke abụọ ma ọ bụ atọ ụbọchị na-atụ aro ka 1.2 g, na, ma ọ bụrụ na ọ dị mkpa, ofu site na ịga dibịa, - ruo 2.4 g, nkerisi ya agba atọ.

Duration nke N'ezie na-adabere na ọdịdị nke na-egosi, sitere na site 4 izu 1.5 ma ọ bụ ọbụna ọnwa 3.

Mgbe urokoproporfirii kenyere kwa ụbọchị dose 0,8 g, na-anata 200 mg Inosine 4 ugboro. Medicine "Riboksin" ile a oge nke 1 3 ọnwa -x.

Mgbe igba ogwu n'akwara ntapu ma ọ bụ na-adasị malite dose nke 200 mg na-ahọrọ otu oge, mgbe ụba 400 mg, iche site na 1-2 dropper kwa ụbọchị. The ọgwụgwọ, dọkịta na-esetịpụrụ n'otu n'otu, dabere na ọrịa na-arịa.

"Riboksin" ndu mmetụta

Na obere okwu, nfụkasị Jeremaya ahụ nwere ike ime urticaria, pruritus, flushing nke anụ. Mmetụta ọjọọ na-apụ n'anya mgbe ọgwụ ndọrọ ego.

Na obere okwu, n'ihi na n'ikuku nke inosine ama ọkọri ego nke uric acid n'ime ọbara iyi. N'ihi ya, ọrịa ẹkenọde ogologo mkpesa nke na-akawanye njọ gout.

"Riboksin" ntụziaka na contraindications

Ị gaghị idepụta ọgwụ inosine ndị mmadụ na hypersensitivity ka otu n'ime mmiri nke na ọgwụ maka gout na hyperuricemia.

E nwere contraindications na iji "riboksin" ọrịa na-ata ahụhụ site na fructose ekweghị ibe nọrọ, a syndrome nke malabsorption nke glucose na / ma ọ bụ galactose-kọrọ na ahụ sucrase na / ma ọ bụ isomaltase.

Inosine ọgwụgwọ nke ọrịa na gbasara akụrụ odida ma ọ bụ ọrịa shuga a rụrụ naanị n'okpuru nlekọta nke a dọkịta, nhọpụta nke ọgwụ ọjọọ na-achọ ịkpachara anya.

Mmetụta nke ọgwụ na nwa ebu n'afọ na ụmụ nwaanyị dị ime na-agaghị, otú ọgwụgwọ "riboksin" n'oge ime na-contraindicated. Safety nke ngwa nke inosine inyom breastfed ụmụ ọhụrụ mmiri ara ehi na a ike. Ya mere, nhọpụta nke "riboksin" na-azụ nwa, ọ na-atụ aro ghara breastfeed.